Healthtech Startups

Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.

2 investors

Wisear develops neural-interface solutions that use biosensing to read and interpret bioelectrical activity, with the goal of integrating this technology into consumer devices such as earphones and AR/VR hardware. The company targets both everyday device manufacturers seeking human-machine interface capabilities and consumers looking for wellness and medical applications.

2 investors

Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine. It serves pharmaceutical and diagnostics companies, supporting biomarker discovery, patient stratification, diagnostics, and therapeutic development.

2 investors

Wolf provides a white-label on-demand staffing platform that helps restaurant operators and hospitality companies match shifts and manage workers for servers, bartenders, cooks, and other restaurant staff. The platform automates shift matching, availability management, credential tracking, and payments for restaurants ranging from single-location operations to enterprise hospitality groups.

2 investors

Wonderbelly manufactures antacid and digestive relief products available in multiple flavors. The company focuses on consumer wellness with thoughtfully formulated ingredients and sustainable packaging.

2 investors

Woolsey Pharmaceuticals Pty Ltd (Woolsey AU) is the Australian subsidiary of Woolsey Pharmaceuticals, Inc., leading the company's corporate research and development activities in Australia. It operates in the pharmaceutical and biotech sector.

2 investors

WorkUp Health operates a platform that partners with health systems to help students discover and pursue clinical careers, connecting each student with resources to support their career journey. It aims to address clinical workforce and staffing shortages in healthcare.

2 investors

Worlds of Hello is a research-driven platform that uses AI voice technology to help children with speech-language disorders practice between therapy sessions. The platform provides emotionally familiar AI voices and automated clinical documentation to reduce therapist burden and improve outcomes for underserved communities.

2 investors

Woven Orthopedic Technologies develops the Ogmend Implant Enhancement System, a surgical implant designed to improve screw fixation in orthopedic and spine surgery for treating complex fixation scenarios.

2 investors

Civica provides cloud software solutions for public sector organisations including local and central governments, healthcare providers, housing, education, and libraries. The company's platforms support critical public services and digital transformation across 6,000+ public bodies globally, serving over 100 million citizens.

2 investors

X-Bolt is a rotationally stable hip fracture fixation implant evaluated in clinical trials for treating unstable femoral fractures. The device demonstrated superior biomechanical performance and lower cut-out rates compared to standard screw fixation in randomized controlled trials.

2 investors

xavveo develops photonic-controlled radar technology for autonomous systems and senior care monitoring, enabling non-invasive environmental detection without cameras or wearables. The company serves autonomous systems manufacturers and elder care providers with AI-powered sensing solutions.

2 investors

xDot Medical is an early-stage medical device company developing an automated vascular closure device that provides instant closure of the access site for catheter-based cardiovascular therapies.

2 investors

2 investors

Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.

2 investors

xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.

2 investors

Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access. The device is intended for MIS surgeons and the surgical device market.

2 investors

Xsensio develops wearable biosensor systems that continuously monitor physiological parameters to detect health risks in real-time. The company aims to commercialize Lab-on-Skin technology for healthcare applications.

2 investors

XY.AI Labs removes operational friction in healthcare by automating administrative tasks, giving clinicians more time for patient care. The company targets healthcare providers and clinics seeking to improve operational efficiency.

2 investors

YCare is an AI-native, multi-tenant operating system designed for at-home care providers, featuring HIPAA compliance and connections to 250+ medical devices and clinical vendors. The platform serves home health agencies and payers by automating operational workflows, clinical decision support, and care delivery coordination.

2 investors

Yeji X builds an AI layer that reads patients' EHR, imaging, and claims data to identify individuals heading toward avoidable cost events and recommend the next best intervention. It serves independent, physician-led value-based care organizations and ACOs carrying two-sided risk in the US healthcare market.

2 investors

Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures, designed to reveal disease markers for earlier diagnosis of conditions affecting the brain, heart, and kidneys. The products are aimed at clinicians and patients needing early diagnosis of these diseases.

2 investors

Yoxly provides at-home sexually transmitted infection test kits that detect common infections such as chlamydia and gonorrhoea, delivering results and treatment guidance through a secure online portal. The service serves individuals seeking private, convenient STI screening with sample collection and lab analysis.

2 investors

A digital service platform for China's out-of-hospital pharmaceutical market, connecting drug manufacturers, distributors, pharmacies, and primary healthcare institutions to enable efficient medicine distribution and access at transparent prices.

2 investors